S-49076

N/A

Report date: 2022/06/01 17:36:05
NME

Base Information

Drug NameS-49076
Drug Alias NameS-49076
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsFibroblast growth factor receptor 3 antagonistsFibroblast growth factor receptor 1 antagonists +[5] 
TargetsFibroblast growth factor receptor 1Fibroblast growth factor receptor 3Fibroblast growth factor receptor 2 +[5] 
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeTaiwanItaly +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut De Recherches Internationales ServierLaboratorios Servier Sl
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A